Millions of breast cancer patients could be spared chemotherapy thanks to groundbreaking gene test
A study that followed more than 4,400 patients aged 40 and over found chemotherapy had 'little or no additional benefit' to people whose tumours had a low Prosigna test score.
Original Source
Read the full article at Dailymail →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.